Biomarin Pharmaceutical - Registered Shares PEG Ratio

Biomarin Pharmaceutical - Registered Shares (BMRN) currently reports a PEG ratio of -177.17. That is below the Healthcare sector average of 11.77. Use the charts on this page to explore Biomarin Pharmaceutical - Registered Shares's PEG ratio history and peer comparisons.

Biomarin Pharmaceutical - Registered Shares's PEG ratio of -177.17 is lower than the Healthcare sector average of 11.77. That is roughly 1605.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Biomarin Pharmaceutical - Registered Shares's market price to a fundamental measure such as earnings, sales, or book value. At -177.17, BMRN can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -177.17, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.77. From there, open related valuation or income-statement pages for Biomarin Pharmaceutical - Registered Shares, and consider following BMRN for alerts when major investors trade the stock.

Biomarin Pharmaceutical - Registered Shares is classified in the Healthcare sector. On PEG ratio, it currently shows -177.17 versus a sector average near 11.77. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BMRN with unrelated industries.